News: R&D

COVID-19 confirmed cases in Indonesia have consistently increased, as of today, there are more than 230,000 active cases. The government has guaranteed the availability of antiviral medicines following the third wave of COVID-19 strikes across the country due to the Omicron variant. Then how is the availability of vitamins in…

The support for Indonesia Indigenous Modern Medicine (OMAI) to be included in the National Health Insurance (JKN) program continues to be supported. This support surfaced in the 2nd Webinar Series held by the University of Indonesia Board of Trustees (MWA UI) with the theme "Indonesian Health Resilience and Independence" on…

Indonesia needs more scientist in the health sector to address various health problems, especially related to the Covid-19 pandemic. For information, the total number of researchers in Indonesia is still minimal. According to the 2017-2045 National Research Master Plan, currently, there are only 80 researchers per 1 million population, while…

Indonesia Indigenous Modern Medicine (OMAI) has been proven preclinically and clinically for the treatment or therapy of disease. At the 2021 Indonesian Medical Herbal Medicine Association Annual Scientific Meeting (PIT PDHMI), scientists and also health practitioners agreed that OMAI could be used for the treatment of patients. "The doctors they…

Farid Nila Moeloek (FNM) Society held a webinar entitled "Use of Herbs to Increase Immunity in the COVID-19 Pandemic". The discussion, which was attended by experts in the health sector, concluded that it was time for Indonesian Original Modern Medicine (OMAI) to be included in the medical education curriculum. "How…

Dexa Group, through PT Dexa Medica, won the 2020 Innovative Industry Award from the Ministry of Research and Technology/National Research and Innovation Agency (Kemenristek/BRIN). The award was given for Dexa Group’s commitment to developing Native Indonesian Modern Medicine (OMAI). The 2020 Innovative Industry Award was opened with remarks from President…

Dexa Group received two prestigious awards from the Ministry of Industry Indonesia, which are the Green Industry Award 2019 through PT Ferron Par Pharmaceuticals and the Technology Pioneer Award 2019 through PT Dexa Medica. The awards were given for the company’s commitment to increasing industry competitiveness around research development and…

Indonesia Indigenous Modern Medicine (OMAI) from Dexa Group, REDACID obtained its Marketing Authorization Number (NIE) as a phytopharmaceutical product from the National Agency of Drug and Food Control (BPOM). This product license is in line with BPOM’s efforts to support the downstreaming of drugs and food research and development through…

Dexa Medica received a prestigious award from the Ministry of Research and Technology and Higher Education (Kemenristekdikti) at the Innovative Industrial Research and Development Institution (IIRDI) Award 2018 for its research and development strategy in producing innovative and quality pharmaceutical products, winning over 40 other institutions in the industry. The…

Director of Innovation and Scientific Development of PT Dexa Medica, Raymond R. Tjandrawinata, Ph.D., M.S., MBA has taken home the SINTA (Science and Technology Index) Awards 2018 in the Author Category of the Scientific Publication with the highest SINTA Score for Private University Category on Wednesday, 4 July 2018. SINTA…